Phylogix Inc. is a biotechnology company focused on tissue protection and oncology. The company develops lectin-based drugs focused on tissue protection, oncology, and immunology. It also involves in the development of FRIL, an agent to protect patients from the toxic side-effects of chemotherapy.
Phylogix Inc. is based in Scarborough, Maine.
Crunchbase Investment Rounds
|Date||Amount||Round||Valuation||Lead Investor||Other Investors|
|2001-11-04||$3,000,000||Series A||Biotechnology Value Fund||Maine Venture Fund|
|2004-03-10||$12,000,000||Series B||Atlas Venture, Prospect Venture Partners||Radius Ventures, Canaan Partners, Biotechnology Value Fund|